PMID: 12777341Jun 5, 2003Paper

Modelling the impact of clozapine on suicide in patients with treatment-resistant schizophrenia in the UK

The British Journal of Psychiatry : the Journal of Mental Science
Andy DugganR Kerwin

Abstract

Schizophrenia is a major cause of suicide, and symptoms characteristic of treatment-resistant disease are strong risk factors. Clozapine reduces symptoms in 60% of such patients and significantly decreases the risk of suicide. To model the impact of increased clozapine prescribing on lives saved and resource utilisation. A model was built to compare current levels of clozapine prescribing with a scenario in which all suitable patients with treatment-resistant schizophrenia received clozapine. It was estimated that an average of 53 lives could be saved in the UK each year. If clozapine is cost-neutral, the cost per life-year saved is pound 5108. If clozapine achieves a 10% reduction in annual support costs, the net saving is pound 8.7 million per annum. An average of 167 acute beds would be freed each year. The use of clozapine in treatment-resistant schizophrenia saves lives, frees resources and is cost-effective.

References

Mar 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·J ModestinD Waldvogel
Apr 1, 1992·Acta Psychiatrica Scandinavica·D E Addington, J M Addington
Aug 1, 1990·Hospital & Community Psychiatry·H Y MeltzerL F Ramirez
Nov 1, 1993·The American Journal of Psychiatry·H Y MeltzerB Snitz
Jan 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·L M Davies, M F Drummond
Mar 1, 1996·Social Psychiatry and Psychiatric Epidemiology·P McCrone, S Weich
Jul 12, 1997·BMJ : British Medical Journal·T Turner
Aug 1, 1997·The British Journal of Psychiatry : the Journal of Mental Science·K J Aitchison, R W Kerwin
Jan 1, 1997·Current Medical Research and Opinion·H Y Meltzer
May 2, 2000·The British Journal of Psychiatry : the Journal of Mental Science·J MunroR Kerwin
Jun 28, 2002·Acta Psychiatrica Scandinavica·Martin KnappUNKNOWN EPSILON. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs

❮ Previous
Next ❯

Citations

Mar 11, 2006·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Karina HansenMondher Toumi
Jul 2, 2005·Nature Genetics·Anna C NeedDavid B Goldstein
Jan 22, 2005·The Australian and New Zealand Journal of Psychiatry·Anne MagnusTheo Vos
Nov 4, 2004·CNS Drugs·Aileen O'Brien
Apr 1, 2005·Indian Journal of Psychiatry·Janakiraman RaguramanR Chandrasekaran
Apr 9, 2014·BMC Psychiatry·Stephanie Warnez, Silvia Alessi-Severini
Apr 28, 2005·Expert Review of Neurotherapeutics·Robert W Kerwin, Anusha A Bolonna
Sep 26, 2015·International Journal of Molecular Sciences·Francisco López-MuñozCecilio Álamo
Oct 12, 2007·International Journal of Law and Psychiatry·Peter F J SchulteAdolph H Heck
Jan 18, 2005·Schizophrenia Research·John Hennen, Ross J Baldessarini
May 20, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·R RajkumarG S Dawe
Jul 19, 2008·Journal of Psychopharmacology·A WheelerG Robinson
Oct 30, 2013·Therapeutic Advances in Psychopharmacology·Al Aditya KhanSamrat Sengupta
May 15, 2008·The Annals of Pharmacotherapy·Amanda J Wheeler
Sep 16, 2017·Crisis·Lizell Bustamante MadsenFlemming Konradsen
Nov 5, 2003·The British Journal of Psychiatry : the Journal of Mental Science·O HowesL S Pilowsky
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Adib EssaliJohn Rathbone
Jun 27, 2017·Journal of Clinical Psychopharmacology·Roisin DoyleMary Clarke
Mar 6, 2018·American Journal of Therapeutics·Peter ManuJimmi Nielsen
Jan 11, 2013·Clinical Schizophrenia & Related Psychoses·Michele Hill, Oliver Freudenreich
Feb 18, 2004·Harvard Review of Psychiatry·Carrie L Ernst, Joseph F Goldberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

The British Journal of Psychiatry : the Journal of Mental Science
J MunroR Kerwin
Clinical Schizophrenia & Related Psychoses
Michele Hill, Oliver Freudenreich
The Australian and New Zealand Journal of Psychiatry
Peter F J SchulteBert Bakker
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Ted Williams, Tara L Purvis
© 2022 Meta ULC. All rights reserved